Ad
CBAY Quote Trading Chart CymaBay Therapeutics Inc.
home / stock / cbay / cbay quote
$4.08 Last:
26.32% Change Percent:
$4 Open:
$3.23 Previous Close:
$4.1 High:
$3.98 Low:
149,588 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CBAY Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-15 | 4 | 3.23 | 4.1 | 3.98 | 149,588 |
| 2022-08-12 | 3.8 | 3.23 | 4.22 | 3.8 | 464,226 |
| 2022-08-11 | 4.2 | 3.23 | 4.23 | 3.73 | 796,154 |
| 2022-08-10 | 4.15 | 3.23 | 4.235 | 4.0093 | 363,477 |
| 2022-08-09 | 4.01 | 3.23 | 4.09 | 3.82 | 624,325 |
| 2022-08-08 | 4.25 | 3.23 | 4.3 | 4.02 | 801,479 |
| 2022-08-05 | 4.08 | 3.23 | 4.25 | 4.0291 | 463,854 |
| 2022-08-04 | 4 | 3.23 | 4.2 | 3.9297 | 924,803 |
| 2022-08-03 | 3.53 | 3.23 | 4.0902 | 3.4994 | 1,454,406 |
| 2022-08-02 | 3.2 | 3.23 | 3.5 | 3.185 | 1,374,701 |
| 2022-08-01 | 3.13 | 3.23 | 3.34 | 3.07 | 632,336 |
| 2022-07-29 | 3.18 | 3.23 | 3.19 | 3.08 | 227,977 |
| 2022-07-28 | 3.23 | 3.23 | 3.25 | 3.1173 | 149,027 |
| 2022-07-26 | 3.11 | 3.11 | 3.3 | 3.101 | 108,770 |
| 2022-07-25 | 3.14 | 3.14 | 3.17 | 3.015 | 250,919 |
| 2022-07-19 | 3.32 | 3.29 | 3.42 | 3.205 | 458,755 |
| 2022-07-18 | 3.4 | 3.22 | 3.46 | 3.2 | 593,720 |
| 2022-07-15 | 3.36 | 3.39 | 3.42 | 3.18 | 572,921 |
| 2022-07-14 | 3.38 | 3.32 | 3.42 | 3.32 | 367,091 |
| 2022-07-13 | 3.31 | 3.43 | 3.46 | 3.2448 | 2,252,031 |
CymaBay Therapeutics Inc. Company Name:
CBAY Stock Symbol:
NASDAQ Market:
CymaBay Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Image source: The Motley Fool. CymaBay Therapeutics Inc. (NASDAQ: CBAY) Q2 2022 Earnings Call Aug 11, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: CymaBay Therapeutics Inc. (CBAY) Q2 2022 Earnings Call Transcript...
-
Enrollment completed in RESPONSE with 193 patients enrolled in over 20 countries Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focuse...
-
NEWARK, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live aud...